Clinical Trial Update: Double-Blind, Double Dummy, Randomized Comparison Study to Evaluate the Efficacy and Safety of Valdecoxib 10 mg Once Daily and Naproxen 500 mg Twice Daily in Treating the Signs and Symptoms of Osteoarthritis of the Knee [Phase 3]

View source ↗

Summary

A completed Phase 3 randomized, double-blind, double-dummy study comparing valdecoxib 10 mg once daily with naproxen 500 mg twice daily for the treatment of sig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Bextra (valdecoxib)
• Naproxen (Naproxen)

Snippet

Sponsor: Pfizer | Conditions: Osteoarthritis, Knee | Phase 3 | Status: COMPLETED